BioMark Diagnostics Inc
CNSX:BUX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
BioMark Diagnostics Inc
CNSX:BUX
|
CA |
|
M
|
Muenchener Rueckversicherungs Gesellschaft in Muenchen AG
DUS:MUV2
|
DE |
|
Hiap Seng Industries Ltd
SGX:1L2
|
SG |
|
F
|
Forcelead Technology Corp
TPEX:6996
|
TW |
|
Braskem SA
BOVESPA:BRKM5
|
BR |
|
PAMT Corp
NASDAQ:PAMT
|
US |
|
Stanmore Resources Ltd
F:S0D
|
AU |
|
Subaru Corp
TSE:7270
|
JP |
|
M
|
Mitsubishi UFJ Financial Group Inc
F:MFZA
|
JP |
|
N
|
Nippon Hume Corp
TSE:5262
|
JP |
|
T
|
Tonnellerie Francois Freres SA
F:5L1
|
FR |
|
Cleantech Vanadium Mining Corp
XTSX:CTV
|
CA |
|
DUG Technology Ltd
ASX:DUG
|
AU |
|
SRJ Technologies Group PLC
ASX:SRJ
|
JE |
|
Raubex Group Ltd
F:B7P
|
ZA |
Bankruptcy Probability
BioMark Diagnostics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
BioMark Diagnostics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
B
|
BioMark Diagnostics Inc
CNSX:BUX
|
50m CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
237.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
431.8B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
BeOne Medicines AG
SSE:688235
|
247.9B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Genmab A/S
CSE:GMAB
|
162.4B DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
|
Biontech SE
NASDAQ:BNTX
|
22.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Medpace Holdings Inc
NASDAQ:MEDP
|
18.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| LU |
|
Eurofins Scientific SE
PAR:ERF
|
14.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Ascendis Pharma A/S
NASDAQ:ASND
|
16.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
BioMark Diagnostics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, BioMark Diagnostics Inc has total debt of 927.8k CAD. This includes both short-term (0 CAD) and long-term (927.8k CAD) debt.
You can find a full breakdown on its Balance Sheet.